Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | BrightSpring Health Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
06.11. | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi | 1 | GlobeNewswire (USA) | ||
BRIGHTSPRING HEALTH SERVICES Aktie jetzt für 0€ handeln | |||||
04.11. | KeyBanc maintains Sector Weight on BrightSpring Health shares | 1 | Investing.com | ||
01.11. | BrightSpring Health Services, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
01.11. | BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | 217 | GlobeNewswire (Europe) | LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
14.10. | BrightSpring Health announces CLO retirement and transition plan | 1 | Investing.com | ||
11.10. | BrightSpring Health Services, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
11.10. | KeyBanc beginnt Berichterstattung über BrightSpring-Aktien mit "Sector Weight"-Einstufung | 1 | Investing.com Deutsch | ||
11.10. | KeyBanc initiates coverage on BrightSpring shares with Sector Weight rating | 2 | Investing.com | ||
03.10. | BrightSpring Health stock bullish as specialty medication trends strengthen-BTIG | 1 | Investing.com | ||
01.10. | BrightSpring Health Services, Inc. to Announce Third Quarter 2024 Financial Results on November 1, 2024 | 1 | GlobeNewswire (USA) | ||
30.09. | BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors | 2 | GlobeNewswire (USA) | ||
30.09. | BrightSpring Health Services, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
14.09. | Walgreens Boots Alliance sells over $1.5 trillion of BrightSpring Health stock | 61 | Investing.com | ||
13.09. | KKR entities purchase $129.3 million in BrightSpring Health stock | 6 | Investing.com | ||
13.09. | KKR erwirbt Walgreens-Anteile an BrightSpring Health | 69 | Investing.com Deutsch | ||
13.09. | KKR buys 11.62M BrightSpring shares from Walgreens | 19 | Seeking Alpha | ||
13.09. | BrightSpring Health Services, Inc.: KKR to Purchase of 11,619,998 Shares of BrightSpring Health Services Common Stock from Walgreens Boots Alliance | 476 | GlobeNewswire (Europe) | LOUISVILLE, Ky., Sept. 13, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services for... ► Artikel lesen | |
03.09. | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Definitive Agreement to Acquire Haven Hospice, Expanding Hospice Services into Florida | 166 | GlobeNewswire (Europe) | LOUISVILLE, Ky., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ: BTSG), a leading provider of home and community-based health services for... ► Artikel lesen | |
22.08. | BrightSpring Health Services, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference | 1 | GlobeNewswire (USA) |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 83,00 | -0,16 % | JPMorgan Chase & Co. Lowers Medtronic (NYSE:MDT) Price Target to $96.00 | ||
INTUITIVE SURGICAL | 500,80 | -0,12 % | Intuitive Surgical Aktie: Frischer Wind für Investoren! | ||
THERMO FISHER | 490,05 | +0,58 % | EQS-News: Mainz BioMed N.V.: Mainz Biomed und Thermo Fisher Scientific unterzeichnen Kooperationsvereinbarung zur Entwicklung von Darmkrebsfrüherkennungstest der nächsten Generation für den globalen Markt | Emittent / Herausgeber: Mainz BioMed N.V.
/ Schlagwort(e): Kooperation
Mainz Biomed und Thermo Fisher Scientific unterzeichnen Kooperationsvereinbarung zur Entwicklung von Darmkrebsfrüherkennungstest... ► Artikel lesen | |
ROKU | 65,65 | +0,44 % | Alphabet, Crowdstrike und Roku mit Fokus auf Allzeithochs | News von Trading-Treff.de Die Aktien von Alphabet, Crowdstrike und Roku zeigen aktuell sehr bullische Chartbilder. Korrekturen nach momentumgetriebenen Rallies bieten aktuell immer wieder gute Chancen... ► Artikel lesen | |
DEXCOM | 72,95 | +1,18 % | Aktie von Dexcom heute am Aktienmarkt gefragt (66,2833 €) | Am US-amerikanischen Aktienmarkt notiert die Aktie von Dexcom zur Stunde ein wenig fester. Die Aktie kostete zuletzt 70,61 US-Dollar. Die Dexcom-Aktie verzeichnet derzeit eine Verteuerung von 0,92 Prozent.... ► Artikel lesen | |
RESMED | 222,40 | -0,27 % | ResMed-Direktor Jan De Witte verkauft Aktien im Wert von 198.052 US-Dollar | ||
ATOSSA THERAPEUTICS | 1,202 | -1,48 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Announced positive topline results from KARISMA-Endoxifen Phase 2 study which demonstrated that low doses of (Z)-endoxifen significantly reduced mammographic breast density (MBD), addressing a key... ► Artikel lesen | |
GE HEALTHCARE TECHNOLOGIES | 77,53 | -0,19 % | GE HealthCare's Head-Only MRI System Gets FDA Clearance | WASHINGTON (dpa-AFX) - GE HealthCare Technologies Inc. (GEHC) Wednesday said that it has received FDA 510(k) clearance for its innovative SIGNA MAGNUS 3.0T high-performance, head-only magnetic... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
ORGANON | 14,150 | -0,88 % | Dividendenbekanntmachungen (12.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECOAGRO SA LU0584671464 0,174 USD 0,1632 EUR ADVANSIX INC US00773T1016 0,16 USD 0,1501 EUR AMERICAN WATER WORKS COMPANY INC US0304201033 0... ► Artikel lesen | |
QUIDELORTHO | 34,400 | 0,00 % | Activist investor Jana cuts Frontier bet, liquidates QuidelOrtho, BlackLine | ||
TEMPEST THERAPEUTICS | 0,842 | -0,18 % | Tempest Therapeutics: Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update | Building upon a successful end-of-Phase 2 meeting, received FDA "Study May Proceed" letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced agreement... ► Artikel lesen | |
VERU | 0,560 | -0,44 % | Veru Inc.: Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results | --Phase 2b QUALITY study of enobosarm in combination with semaglutide (Wegovy®*) exceeds targeted full enrollment of >150 patients-- --Topline data for primary endpoint of lean body mass expected... ► Artikel lesen | |
CENTENE | 54,36 | -0,40 % | Chutes & Ladders-Centene president to retire, Abridge and AccessHope tap industry execs | ||
FULGENT GENETICS | 16,800 | -2,89 % | Fulgent Genetics stock hits 52-week low at $18.76 |